Pallas Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.24 Billion
- Q1 2025
A detailed history of Pallas Capital Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 42,534 shares of APLS stock, worth $774,118. This represents 0.05% of its overall portfolio holdings.
Number of Shares
42,534
Previous 13,369
218.15%
Holding current value
$774,118
Previous $426,000
142.25%
% of portfolio
0.05%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$222 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$216 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$183 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$175 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$105 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...